Juliet Williams

Company: Kymera Therapeutics

Job title: Head of Research

Seminars:

Solving Big Problems with Small Molecule Degraders 5:25 pm

To realize on the promise of this disease-agnostic technology, Kymera has taken a unique approach to target selection, where we focus on targets that are either undrugged or inadequately drugged within key signaling pathways with clear clinical validation and validation through human genetics/causal biology, and where TPD is the best or the only solution Our…Read more

day: Day Two PM